This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
18 Aug 2014

Catalent Confirms the Appointment of Two Senior Healthcare Executives to its Board of Directors

Catalent, Inc., has appointed Jack Stahl and Rolf Classon to its Board of Directors.



Mr Jack Stahl was President and CEO of Revlon, Inc. between 2002 and 2006. Previously, he acted as President and Chief Operating Officer of The Coca-Cola Company from 2000 to 2001. Mr Stahl also serves on the Boards of Coty, Inc., Delhaize Group, and the US Board of Advisors of CVC Capital. In addition, Mr Stahl formerly served on the Boards of Schering-Plough Corporation and Dr Pepper Snapple Group. He holds a Bachelor’s degree in Economics from Emory University and a Master’s degree from the Wharton School of Business at the University of Pennsylvania.



Mr Rolf Classon was Chairman of the Executive Committee at Bayer HealthCare AG, a subsidiary of Bayer AG, from October 2002 until his retirement in July 2004. He served as President of Bayer Diagnostics from 1995 to 2002 and as Executive Vice President from 1991 to 1995. Prior to 1991, Mr Classon held various management positions with Pharmacia Corporation. Mr Classon currently serves as Chairman of the Boards of Auxilium Pharmaceuticals, Inc., Hill-Rom Corporation, and Tecan Group Ltd, and he serves on the Board of Fresenius Medical Care. Mr Classon served as Vice Chairman of Auxilium Pharmaceuticals, Inc. from March 2005 to April 2005, and he was interim CEO of Hill-Rom Corporation from May 2005 until March 2006. Mr. Classon also served as a Director on the Boards of Millipore Corporation, Prometheus Laboratories Inc., and Enzon Pharmaceuticals, Inc. Mr. Classon received his Chemical Engineering Certificate from the Gothenburg School of Engineering and a Business degree from the Gothenburg University.



Messrs. Stahl and Classon have also joined Catalent’s Audit Committee, with Mr Stahl serving as Chair.



“We welcome both Jack and Rolf to our Board,” commented John Chiminski, President and CEO, Catalent, Inc. “Both are senior healthcare executives, with a wealth of knowledge and experience within the sector. We will look to draw upon their expertise as we embark on the next, exciting stage of our company’s history.”

Related News